Research ArticleClinical Investigation
Biokinetics and Dosimetry of 177Lu-Pentixather
Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm and Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: https://doi.org/10.2967/jnumed.121.262295
Heribert Hänscheid
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Andreas Schirbel
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Philipp Hartrampf
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Sabrina Kraus
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
Rudolf A. Werner
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Hermann Einsele
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
Hans-Jürgen Wester
3Department of Pharmaceutical Radiochemistry, TU Munich, Munich, Germany
Michael Lassmann
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Martin Kortüm
2Department of Internal Medicine II, University Hospital Würzburg, Würzburg, Germany; and
Andreas K. Buck
1Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany;
Data supplements
Supplemental Data
Files in this Data Supplement:
In this issue
Journal of Nuclear Medicine
Vol. 63, Issue 5
May 1, 2022
Biokinetics and Dosimetry of 177Lu-Pentixather
Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295
Biokinetics and Dosimetry of 177Lu-Pentixather
Heribert Hänscheid, Andreas Schirbel, Philipp Hartrampf, Sabrina Kraus, Rudolf A. Werner, Hermann Einsele, Hans-Jürgen Wester, Michael Lassmann, Martin Kortüm, Andreas K. Buck
Journal of Nuclear Medicine May 2022, 63 (5) 754-760; DOI: 10.2967/jnumed.121.262295
Jump to section
Related Articles
Cited By...
- Limitations of the radiotheranostic concept in neuroendocrine tumors due to lineage-dependent somatostatin receptor expression on hematopoietic stem and progenitor cells
- CXCR4-Directed Imaging and Endoradiotherapy in Desmoplastic Small Round Cell Tumors
- Theranostics in Hematooncology
- Detecting CXCR4 Expression in Meningioma on 68Ga-Pentixafor PET/MRI
- C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Patients with Advanced T-Cell Lymphoma